Chris Novak: Welcome to Pivot Health! I'm Chris—
Maya Johnson: —and I'm Maya. Let's get into it.
Chris Novak: Today we're covering AI chatbots giving dangerous medical advice, the massive economic threat from declining vaccination rates, and Science Corp's first human brain implant.
Maya Johnson: Starting with those AI chatbots — Chris, this new study is honestly terrifying. We're talking about AI systems giving problematic medical advice literally half the time. That's not a small error rate, that's a coin flip between helpful and harmful.
Chris Novak: Yeah, and what makes this particularly concerning is how quickly these tools are being adopted. I've seen health systems racing to implement chatbots for everything from triage to symptom checking. But if they're wrong 50% of the time? That's not disruption, that's destruction.
Maya Johnson: Exactly. From a clinical perspective, we'd never accept a diagnostic tool with 50% accuracy. The real danger is that patients often can't distinguish between good and bad AI advice. They see a polished interface, articulate responses, and assume it's trustworthy.
Chris Novak: I think the core issue here is that these models are trained on internet data, not validated medical knowledge. They're pattern matchers, not doctors. And honestly, the tech companies know this — they just slap on disclaimers and ship it anyway.
Maya Johnson: What worries me most is vulnerable populations — elderly patients, those with limited health literacy, people without regular doctor access. They're most likely to rely on these tools and least equipped to spot dangerous advice.
Chris Novak: So what's the solution? Because I don't think we can put this genie back in the bottle.
Maya Johnson: We need rigorous clinical validation before deployment, period. These tools should go through something similar to FDA device approval. And until then? Health systems need to pump the brakes on implementation.
Chris Novak: Moving to our second story — declining vaccination rates could cost the US nearly 8 billion dollars in measles outbreaks over the next five years. Maya, those numbers are staggering.
Maya Johnson: The economic angle is important, but let's talk about what this really means — we're looking at potentially thousands of preventable cases of a disease we had essentially eliminated. Measles isn't just a rash. It kills. It causes brain damage. It wipes out immune memory.
Chris Novak: And that 7.8 billion? That's just direct costs — hospitalizations, treatments, outbreak responses. It doesn't capture lost productivity, long-term complications, or the strain on our already overwhelmed healthcare system.
Maya Johnson: What's driving this is a perfect storm — pandemic-related disruptions to routine care, growing vaccine hesitancy, and frankly, people forgetting how devastating these diseases were. We have a generation of parents who've never seen measles kill a child.
Chris Novak: The tech angle here is interesting too. Social media algorithms are amplifying anti-vaccine content at unprecedented scales. We're seeing AI-generated misinformation that's increasingly sophisticated and harder to counter.
Maya Johnson: And once vaccination rates drop below 95%, we lose herd immunity. That's when outbreaks explode. We're already seeing pockets of the country dipping dangerously close to that threshold.
Chris Novak: Honestly, this feels like a massive public health own-goal. We have safe, effective vaccines, and we're choosing to let coverage decline.
Maya Johnson: The solution has to be multi-pronged — better education, combating misinformation, making vaccines more accessible. But we need to act now. Once an outbreak starts, it's exponentially harder and more expensive to control.
Chris Novak: Alright, let's shift gears to something more futuristic — Science Corp is about to implant its first brain sensor in a human. This is Max Hodak's company, he was a Neuralink co-founder, and they're taking a different
